Stock fact sheet · data as of
Escalon Medical Corp. (ESMC): fair value, margin of safety and Wheel Score
Healthcare · Medical - Devices · United States · High Growth
Is ESMC undervalued?
At 0.1800 (close of 16 Oct 2026), ESMC trades 99% below the GLS average fair value of 32.38. That average comes from 7 models run on the latest filings, and 7 of them land above the current price. Margins of safety over 30% are the exception rather than the rule across the ~7,400 stocks we value each night, so the number earns Escalon Medical Corp. the full Value points in the Wheel Score - and a closer look at what the market is pricing in.
The 7 models disagree widely: Graham Number gives 3.12 while 10 Cap gives 86.33. A spread that wide means the average is sensitive to which methods you trust; the model table below shows where each one lands, and the Quote page lets you switch any of them off.
The nightly engine files ESMC under High Growth: revenue and earnings growing fast enough that the growth-based models carry the valuation.
Nine valuation models for ESMC
Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.
| Model | Value | vs price | What it measures |
|---|---|---|---|
| DCF | - | - | Present value of the projected free cash flows, discounted at the cost of capital; no value tonight |
| Graham Number | 3.12 | +1633% | The most a defensive investor pays for the earnings and book value per share |
| Graham Growth | 30.95 | +17096% | Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields |
| Lynch | 13.53 | +7416% | EPS × the earnings growth rate (PEG of 1), growth capped at 25% |
| GLS Growth | 33.13 | +18304% | EPS compounded ten years at the blended growth rate, discounted back at 15% a year |
| 10 Cap | 86.33 | +47860% | Owner's earnings (operating cash flow less maintenance capex) capitalised at 10% |
| Payback Time | 53.57 | +29660% | Eight years of compounded free cash flow: the price at which the business pays for itself |
| DDM | - | - | Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight |
| EPV | 6.01 | +3240% | Earnings power value: current EPS capitalised at 9% with no growth |
| Zombie (liquidation) | 514.01 | +285460% | Current assets less all liabilities, per share: the balance-sheet floor. Not in the average |
| Wall St target | 0.0000 | -100% | Analysts' average 12-month price target. Not in the average |
Quality and financial health
Financial health is average - ESMC passes 6 of the nine Piotroski tests, which passes the Sunday Scan's "6 or more" rule. The Financials tab on the Quote page shows which tests fail. The GLS Moat score is 5.8 out of 10: a ten-year record that is consistent in some of the metrics the score tracks (revenue, earnings, margins, cash flow, returns on capital) and patchy in others.
Returns on capital are high - ROIC 476.1%, ROE 67692.4%, ROA 44.0% - with debt at 141.17 times equity and a free-cash-flow yield of 2200.4%. Debt of 141.17 times equity is on the high side for the sector and is worth checking against the cash flow before treating the stock as a long-term hold.
Escalon Medical Corp. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Product 95%, Service 5% (quarter Q3 FY2026).
Institutional ownership scores 5/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.
| Piotroski F-score | 6 / 9 | ROIC | 476.1% |
|---|---|---|---|
| GLS Moat | 5.8 / 10 | ROE | 67692.4% |
| Debt / equity | 141.17 | ROA | 44.0% |
| Free-cash-flow yield | 2200.4% | Payout ratio | 0% |
| Institutions | 5 / 10 | Insiders · Congress | 5 · 5 / 10 |
Wheel Score 39: No options
ESMC has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business; the Wheel Score is capped at 39 and shown as "No options" (39 here). The valuation and quality numbers still apply to owning the shares outright.
Volume runs at 35k shares a day on a market cap of $1M, with a beta of 0.21 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score gives that 6 of 20.
| Part | Points | From | |
|---|---|---|---|
| Value | 25 / 25 | 99% margin of safety | |
| Health | 13 / 20 | Piotroski 6/9 | |
| Moat | 9 / 15 | moat 5.8/10 | |
| Premium | 0 / 20 | no option data | |
| Stability | 6 / 20 | 35k shares/day, $1M cap, beta 0.21 |
The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.
Upcoming events
No upcoming earnings date is recorded for ESMC in the nightly calendar.
Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.
Similar stocks in Medical - Devices
The 12 companies below are the closest to Escalon Medical Corp. by market cap within the Medical - Devices industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.
| Stock | Close | Fair value | MoS | Wheel | Mkt cap |
|---|---|---|---|---|---|
| XAIR Beyond Air, Inc. | 2.10 | 12.11 | +83% | 39No options | $1M |
| TNON Tenon Medical, Inc. | 2.82 | - | - | 30No options | $1M |
| PFSA Profusa, Inc. Common Stock | 1.28 | - | - | 30No options | $1M |
| AMIX Autonomix Medical, Inc. | 2.93 | 18.46 | +84% | 38No options | $2M |
| NXL Nexalin Technology, Inc. | 2.45 | - | - | 22No options | $2M |
| VVOS Vivos Therapeutics, Inc. | 0.1340 | - | - | 27No options | $2M |
| VNRX VolitionRX Ltd | 0.1790 | - | - | 39Weak | $2M |
| BJDX Bluejay Diagnostics, Inc. | 0.7793 | 10.79 | +93% | 39No options | $806K |
| POAS Phaos Technology Holdings (Caym | 2.43 | - | - | 14No options | $2M |
| ADGM Adagio Medical Holdings, Inc. | 0.1030 | - | - | 30No options | $2M |
| ICCM IceCure Medical Ltd | 1.04 | - | - | 32No options | $2M |
| CYDX CYduct Diagnostics, Inc. | 0.5000 | 0.0180 | -2681% | 20No options | $3M |
Screen the whole market the same way
A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.
Start free See the Sunday ScanQuestions about ESMC
Is ESMC undervalued right now?
By the GLS models, yes: at 0.1800 the stock is 99% below the average fair value of 32.38 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.
What is the Wheel Score of ESMC and what does it mean?
ESMC has no listed options in our nightly snapshot, so it cannot be wheeled; its Wheel Score is capped at 39 and shown as "No options".
What is the GLS fair value for ESMC?
32.38 per share as of 16 Oct 2026 - the simple average of the 7 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.
When does Escalon Medical Corp. report earnings next?
No upcoming earnings date is recorded for ESMC in our calendar as of 16 Oct 2026; the Calendars page is refreshed every morning.
Does ESMC have listed options, and how liquid are they?
No. The nightly options snapshot found no listed contracts on ESMC, so the wheel strategy cannot be run on it and the Wheel Score is capped at 39.